Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Rainbow Childrens Medicare Ltd

RAINBOW
NSE
1,264.20
1.80%
Last Updated:
29 Apr '26, 4:00 PM
Company Overview
Guidance Tracker
Alert
Watchlist
Note

Rainbow Childrens Medicare Ltd

RAINBOW
NSE
1,264.20
1.80%
29 Apr '26, 4:00 PM
Company Overview
Guidance Tracker
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
12,839Cr
Close
Close Price
1,264.20
Industry
Industry
Hospitals
PE
Price To Earnings
49.83
PS
Price To Sales
7.96
Revenue
Revenue
1,613Cr
Rev Gr TTM
Revenue Growth TTM
8.50%
PAT Gr TTM
PAT Growth TTM
8.85%
Peer Comparison
How does RAINBOW stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
RAINBOW
VS

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
317287333336341330417398370353445445
Growth YoY
Revenue Growth YoY%
49.221.16.39.77.615.025.518.58.56.96.511.9
Expenses
ExpensesCr
219199215218236237270264255249296298
Operating Profit
Operating ProfitCr
988811811810694147134115104149147
OPM
OPM%
30.930.535.335.130.928.435.233.831.029.433.533.0
Other Income
Other IncomeCr
9889131211131520811
Interest Expense
Interest ExpenseCr
141513141718181818181920
Depreciation
DepreciationCr
232527283234353534343640
PBT
PBTCr
70568585695310594777110298
Tax
TaxCr
161422221814262520182724
PAT
PATCr
544163635140796957547674
Growth YoY
PAT Growth YoY%
339.37.02.77.4-5.2-4.225.110.210.735.4-4.37.2
NPM
NPM%
17.014.419.018.615.012.018.917.315.315.317.016.6
EPS
EPS
5.34.06.26.15.03.97.86.85.55.37.47.1

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
1692333214025437196509741,1741,2971,5161,613
Growth
Revenue Growth%
37.937.925.135.132.5-9.649.820.510.516.96.4
Expenses
ExpensesCr
1292052683353945224876697778681,0261,099
Operating Profit
Operating ProfitCr
40285367149197163305396429490514
OPM
OPM%
23.611.916.516.727.427.425.131.333.833.132.331.9
Other Income
Other IncomeCr
10161110810101931375153
Interest Expense
Interest ExpenseCr
22123945445355597275
Depreciation
DepreciationCr
91822286069738390112138144
PBT
PBTCr
38244147589356187282295330348
Tax
TaxCr
13710101338164969778689
PAT
PATCr
25173136455540139212218244260
Growth
PAT Growth%
-31.885.315.722.924.1-28.5250.553.12.811.96.4
NPM
NPM%
14.77.39.89.08.27.76.114.218.116.816.116.1
EPS
EPS
26.418.27.08.14.86.04.414.820.921.424.025.4

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
9994444444494102102102102
Reserves
ReservesCr
1662753083073173513914989581,1571,3671,416
Current Liabilities
Current LiabilitiesCr
3542567092130122125144149151208
Non Current Liabilities
Non Current LiabilitiesCr
15131415463480511564567756751845
Total Liabilities
Total LiabilitiesCr
2313493994489261,0191,0811,2961,7762,1702,3772,587
Current Assets
Current AssetsCr
9817112573133203197290484622822728
Non Current Assets
Non Current AssetsCr
1341792743757948178841,0061,2931,5491,5551,859
Total Assets
Total AssetsCr
2313493994489261,0191,0811,2961,7762,1702,3772,587

Cash Flow

Consolidated
Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
26173648127170143224327321396
Investing Cash Flow
Investing Cash FlowCr
-20-107-33-42-117-117-83-175-465-226-268
Financing Cash Flow
Financing Cash FlowCr
-793-1-7-9-52-61-44143-102-118
Net Cash Flow
Net Cash FlowCr
-131-222-145-710
Free Cash Flow
Free Cash FlowCr
-35-46-21-103429667162186-32250
CFO To PAT
CFO To PAT%
102.8101.7113.3132.1285.4307.9360.7161.3154.1147.2162.0
CFO To EBITDA
CFO To EBITDA%
63.962.267.171.585.786.587.673.482.574.980.8

Ratios

Consolidated
Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
000000007,41213,17514,214
Price To Earnings
Price To Earnings
0.00.00.00.00.00.00.00.035.260.758.4
Price To Sales
Price To Sales
0.00.00.00.00.00.00.00.06.310.29.4
Price To Book
Price To Book
0.00.00.00.00.00.00.00.07.010.59.7
EV To EBITDA
EV To EBITDA
-1.4-5.1-1.4-0.32.62.02.61.320.032.530.5
Profitability Ratios
Profitability Ratios
GPM
GPM%
82.982.983.985.185.285.484.180.086.587.387.1
OPM
OPM%
23.611.916.516.727.427.425.131.333.833.132.3
NPM
NPM%
14.77.39.89.08.27.76.114.218.116.816.1
ROCE
ROCE%
21.48.612.713.411.715.610.520.520.717.518.0
ROE
ROE%
14.16.09.910.312.314.09.123.420.017.316.6
ROA
ROA%
10.74.87.98.14.85.43.710.712.010.110.3
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
### **Overview** Rainbow Childrens Medicare Ltd (RCML) is India’s **largest private, standalone pediatric and perinatal healthcare provider**, operating a highly scalable and integrated **hub-and-spoke model** across 22 hospitals and 5 clinics in 9 cities. With approximately **2,300 beds**, the company delivers comprehensive, child-centric care, focusing on **tertiary and quaternary pediatric services**, multispecialty treatments, and advanced maternal/obstetric care under the **‘Birthright by Rainbow’** brand. RCML has established itself as a **pioneer in pediatric and mother-and-child healthcare**, with a strong emphasis on **clinical excellence, innovation, and doctor engagement**, backed by **NABH and JCI accreditations**. --- ### **Key Network & Infrastructure (Sep 2025)** - **22 Hospitals** and **5 Clinics** across **Hyderabad, Bengaluru, Chennai, Delhi, Vijayawada, Visakhapatnam, Warangal, Guwahati, and Rajahmundry**. - Total **bed capacity**: ~2,300, with **~1/3rd dedicated to critical care** (NICU/PICU). - **Hub hospitals (200–250 beds)** offer **tertiary and quaternary care** (e.g., organ transplant, ECMO, pediatric neurosurgery). - **Spoke hospitals (50–100 beds)** provide **primary, secondary, and emergency care**, Level 3 NICUs, 24/7 deliveries, and large OPD services. --- ### **Strategic Growth & Expansion** #### **1. Hub-and-Spoke Model Expansion** - **Established in Hyderabad**, scaling successfully in **Bengaluru**, and now being replicated in **Chennai and the National Capital Region (NCR)**. - Planned expansion into **Tier-2 cities across Southern India** (e.g., Coimbatore, Rajahmundry). - **Regional spokes** located 200–250 km from hubs extend access to underserved areas. #### **2. New Projects & Capacity Additions** - **Rajahmundry (100-bed hub)**: Serves the Godavari belt (10–12 million population); operational pending final approvals. - **Coimbatore (130-bed hub)**: Under construction; to become a **regional super-specialty hub for Tamil Nadu**. - **Bengaluru**: - 90-bed hospital in **Electronic City** (Q2 FY2026 launch) - 60-bed facility in **Hennur** (Q2 FY2026 launch) - **Gurugram (NCR)**: - 325-bed hub in Sector 44 - 125-bed spoke in Sector 56 - Total: 450-bed asset-heavy expansion into **North India**, pending approvals. #### **3. Future Expansion Roadmap** - Plans to add **~800 beds over the next 3 years**, with **50% via asset-light (build-to-suit, greenfield) models**. - **Strategic focus** on high-growth geographies: **NCR, Southern India, and Northeast India**. #### **4. Strategic Acquisitions & Partnerships** - **Acquired 76% stake in Prashanthi Hospital, Warangal (100 beds)** – expands leadership in North Telangana. - **76:24 partnership with Pratiksha Hospitals, Guwahati**: - Rebrands as **‘Pratiksha Rainbow Children’s Hospital’** and **‘Birthright by Rainbow Hospitals’**. - 150-bed facility (100 active; 50 to be commissioned) – positioned as **first comprehensive pediatric super-specialty hub in Northeast India**. - Serves **seven northeastern states, Bhutan, Bangladesh, and Myanmar** – ideal for **pediatric medical tourism**. --- ### **Clinical & Service Offerings** | **Brand** | **Services** | |----------|-------------| | **Rainbow Children's Hospital** | - Neonatal and Pediatric Intensive Care<br>- Multi-specialty pediatric care<br>- Organ Transplants (Liver, Kidney, Bone Marrow)<br>- Pediatric Cardiac Surgery & Intervention<br>- Pediatric Oncology, Neurology, Nephrology<br>- 24x7 Emergency & Retrieval Services | | **Birthright by Rainbow** | - High-Risk Obstetric Care<br>- Fetal Medicine & Genetics<br>- In Vitro Fertilization (IVF)<br>- Gynecological Care & Natural Birthing | - **IVF services**: Operational in **12 centers**, contributing **~3.2% of revenue**, with **50% YoY volume growth**. - **Transplant Programs**: Active kidney, bone marrow, and liver transplant programs across Hyderabad, Bengaluru, and Chennai. First liver transplant completed in Chennai in 2025. --- ### **Innovation & Clinical Leadership** - **Dr. Nageswara Rao Koneti**, Director of Rainbow Children’s Heart Institute, holds a **U.S. FDA patent** for the **KONAR-MF Occluder**, a device used to treat ventricular septal defects. Successfully deployed in **18,000+ patients across 90 countries**. - **World-first fetal procedure** performed: **in-utero balloon valvuloplasty** with a novel closure device, saving a 700g fetus. - Hosts **India’s largest private DNB pediatric training program** – over **230 trainees**; recognized as a **UK MRCPCH examination center**. --- ### **Doctor Engagement & Talent Model** - **>910 full-time doctors** on retainer-based contracts with **24x7 availability**. - Doctors **do not run private clinics**, ensuring **institution-first focus** and **high retention**. - Multidisciplinary, team-based approach enhances emergency and critical care delivery. - **Clinical excellence** ensured by specialists trained in the **US, UK, Canada, and Australia**. --- ### **Medical & Business Model Highlights** | Feature | Detail | |--------|--------| | **Hub-and-Spoke Model** | Central hubs for quaternary care; spokes for accessibility and emergency care | | **Child-Centric Infrastructure** | Vibrant interiors, play areas, trauma-informed design | | **Revenue Mix** | ~50% insurance, ~50% out-of-pocket | | **Revenue Drivers** | ICU care, quaternary procedures, IVF, deliveries | | **ARPP Growth (YoY)** | +3% (Inpatient), +8% (Outpatient) | | **Medical vs. Surgical** | 75–80% medical, 20% surgical (low volume, high complexity) | | **Growth CAGR** | 16% over 3 and 5 years (per management) | --- ### **Digital & Operational Transformation** - **Digitized core systems**: Migrated **Hospital Information System (HIS) to AWS**, enabling real-time connectivity across network. - **AI-enabled content engine, chatbot (website/WhatsApp), and mobile app** for booking, payments, and consultations. - **Telemedicine** with hybrid model: hub doctors support spoke clinics remotely. - **AI-powered EMR, virtual ICU**, and process automation (RPA) under development. --- ### **Accreditations & ESG** - **13 NABH-accredited** hospitals, **3 JCI-accredited** – making Rainbow the **only pediatric hospital chain in India with 3 JCI facilities**. - **Birthright Fertility (Kondapur)** is **India’s first JCI-accredited fertility center**. - **Three hospitals have EDGE certification** for sustainability. - Self-funded expansion: all capital expenditures to be funded via **internal accruals and cash reserves**. --- ### **Financial & Operational Metrics (Selected, FY2024)** - **Revenue**: ₹12,969 million | **EBITDA**: ₹4,289 million | **PAT**: ₹2,183 million - **Patient Footfall**: - Outpatient visits: 1.24 million - Inpatient admissions: 87,736 - Deliveries: 15,798 - **Organ Transplants**: 75+ (2024) - **Cardiac Surgeries**: 1,000+ (2024) --- ### **Strategic Positioning & Competitive Edge** - **First-mover advantage** in standalone pediatric hospitals with integrated perinatal care. - **Only pediatric chain** with multi-organ transplant, Level 4 NICUs, and IVF under one roof. - **Hybrid digital+physical model** strengthens reach and patient loyalty. - **Hub-and-spoke + asset-light expansion** enables efficient, scalable growth. - **Doctor-led, consultant-driven model** ensures consistent, high-quality care.